BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31646802)

  • 1. Management of malignant and borderline phyllodes tumors of the breast: our experience.
    Zervoudis S; Xepapadakis G; Psarros N; Bothou A; Tsikouras P; Galazios G; Kontogianni P; Papazian M; Navrozoglou I; Iatrakis G; Paschopoulos M
    J BUON; 2019; 24(4):1521-1525. PubMed ID: 31646802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.
    Fajdić J; Gotovac N; Hrgović Z; Kristek J; Horvat V; Kaufmann M
    Onkologie; 2007 Mar; 30(3):113-8. PubMed ID: 17341897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Characteristics and Patient Outcomes of Phyllodes Tumors: A Single Institution Experience.
    Mohan SC; Tseng J; Angarita S; Marumoto A; Dadmanesh F; Amersi F; Giuliano A; Chung A
    Am Surg; 2021 Dec; 87(10):1533-1538. PubMed ID: 34689588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.
    Spanheimer PM; Murray MP; Zabor EC; Stempel M; Morrow M; Van Zee KJ; Barrio AV
    Ann Surg Oncol; 2019 Jul; 26(7):2136-2143. PubMed ID: 30783853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extent of surgery and prognosis of patients with phyllodes tumor of the breast.
    Zissis C; Apostolikas N; Konstantinidou A; Griniatsos J; Vassilopoulos PP
    Breast Cancer Res Treat; 1998 Apr; 48(3):205-10. PubMed ID: 9598867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
    Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
    Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.
    Wang H; Wang X; Wang CF
    Asian Pac J Cancer Prev; 2014; 15(24):10791-5. PubMed ID: 25605178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective review of phyllodes tumours of the breast: A single institution experience.
    Ganesh V; Drost L; Lee J; Wan BA; Zhang L; Rakovitch E; Vesprini D; Slodkowska E; Zeng KL; Sousa P; Yee C; Lam H; Chow E
    Breast; 2018 Apr; 38():52-57. PubMed ID: 29232600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases.
    Reinfuss M; Mituś J; Duda K; Stelmach A; Ryś J; Smolak K
    Cancer; 1996 Mar; 77(5):910-6. PubMed ID: 8608483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors.
    Barth RJ
    Breast Cancer Res Treat; 1999 Oct; 57(3):291-5. PubMed ID: 10617306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast.
    Abdalla HM; Sakr MA
    J Egypt Natl Canc Inst; 2006 Jun; 18(2):125-33. PubMed ID: 17496937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
    Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
    ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.
    Rodrigues MF; Truong PT; McKevitt EC; Weir LM; Knowling MA; Wai ES
    Cancer Radiother; 2018 Apr; 22(2):112-119. PubMed ID: 29523388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phyllodes tumour of the breast and margins: How much is enough.
    Ogunbiyi S; Perry A; Jakate K; Simpson J; George R
    Can J Surg; 2019 Feb; 62(1):E19-E21. PubMed ID: 30694037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phyllodes tumors of the breast: a case series of 106 patients.
    Ben Hassouna J; Damak T; Gamoudi A; Chargui R; Khomsi F; Mahjoub S; Slimene M; Ben Dhiab T; Hechiche M; Boussen H; Rahal K
    Am J Surg; 2006 Aug; 192(2):141-7. PubMed ID: 16860620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
    Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
    J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
    Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of phyllodes breast tumors.
    Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
    Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Recurrence of Malignant Phyllodes Tumors of the Breast.
    Park HJ; Ryu HS; Kim K; Shin KH; Han W; Noh DY
    In Vivo; 2019; 33(1):263-269. PubMed ID: 30587634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08).
    Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
    Clin Breast Cancer; 2019 Oct; 19(5):345-353.e2. PubMed ID: 31103280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.